Clinical Trials Directory

Trials / Completed

CompletedNCT03747003

Gonadal Function in Young to Middle Aged HIV-infected Men

Gonadal Function in Young to Middle Aged HIV-infected Men Assessed by Isotopic Dilution-liquid Chromatography-mass Spectrometry (ID-LC-MS/MS) and Chemiluminescent Immunoassay

Status
Completed
Phase
Study type
Observational
Enrollment
315 (actual)
Sponsor
Azienda Ospedaliero-Universitaria di Modena · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

HIV infection is associated to premature decline of serum testosterone. However, prevalence and biochemical characterization of hypogonadism in HIV-infected men are still to be well defined. HIV-infection is strongly associated to erectile dysfunction in men, but preliminary data suggest that it is poorly associated with serum testosterone in this context.

Detailed description

The aim of this study is to evaluate the gonadal function of young to middle aged HIV-infected men in order to characterize hypogonadism by assessing circulating total testosterone with either Liquid Chromatography tandem Mass Spectrometry (LC-MS/MS) or chemiluminescent immunoassay. Furthermore, secondary aim is to assess the erectile function through the use of validated questionnaires (International Index of Erectile Function (IIEF) 15 and 5).

Conditions

Interventions

TypeNameDescription
OTHERNo intervention is providedNo intervention is provided

Timeline

Start date
2013-05-15
Primary completion
2017-12-31
Completion
2018-12-31
First posted
2018-11-20
Last updated
2021-02-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03747003. Inclusion in this directory is not an endorsement.